Deciphering the potential ability of DExD/H-box helicase 60 (DDX60) on the proliferation, diagnostic and prognostic biomarker in pancreatic cancer: a research based on silico, RNA-seq and molecular biology experiment
In summary, DDX60 can be used as a novel biomarker related to the diagnosis and treatment of pancreatic cancer, participate in tumor proliferation, and is associated with poor prognosis in patients.
Authors
- Xiaohua Jiang (ORCID: https://orcid.org/0000-0002-0923-4482)
- Yuze Sun (ORCID: https://orcid.org/0009-0006-3910-2970)
- Peiji Zeng (ORCID: https://orcid.org/0009-0003-8506-3835)
- Dongdong Zhang (ORCID: https://orcid.org/0000-0002-4640-7522)
- Yun Cai (ORCID: https://orcid.org/0000-0001-9777-7745)
- Enze Zhang (ORCID: https://orcid.org/0000-0002-1823-8178)
- Yifan Lian (ORCID: https://orcid.org/0000-0003-2656-0762)
Institutions
- Xiamen University (CN)
- Zhongshan Hospital of Xiamen University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1186/s41065-024-00361-9
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China